BioGaia AB (STO:BIOGB) BioGaia has signed an agreement with Delta Medical Promotions A.G., Switzerland which gives the company exclusive rights to sell BioGaia's Probiotic Drops in Kazakhstan and BioGaia's Probiotic tablets in Ukraine and Kazakhstan.
The drops have already been successfully launched in Ukraine by Delta Medical.
" We have been positively surprised by the rapid success that we have achieved in the Ukrainan market. This agreement means that the BioGaia's brand will be exposed in yet another market and that we can offer a broader product line in these countries", says Peter Rothschild, President, BioGaia AB.
"We see the addition of tablets as a natural step to build on our successful launch of the BioGaia Probiotic drops in Ukraine. Kazakhstan is a strategic market of 16 million people and we believe BioGaia is well positioned to achieve significant market share" says William Wickham, General Director, Delta Medical.
Latest press releases from BioGaia: 2008-11-10 Product from BioGaia counteracts bleeding gums by interacting with the immune system 2008-10-23 BioGaia AB Interim report 1 January - 30 September 2008 2008-10-08 BioGaia invests in LifeTop Cap in new subsidiary
For additional information contact: Peter Rothschild, Managing Director, telephone: +46 8 - 555 293 00, Jan Annwall, Deputy Managing Director telephone: +46 8 - 555 293 00
BioGaia is a biotechnology company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Small Cap list of the Nordic Stock Exchange in Stockholm. www.biogaia.com
This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
LINK:
http://hugin.info/86913/R/1269509/280771.pdfBioGaia AB
http://www.biogaia.seISIN: SE0000470395
Stock Identifier: XOME.BIOGB
News 
